
In collaboration with Davidson College, this specialization is intended for a graduate level audience with a life sciences background seeking to learn about preclinical drug discovery. Preclinical drug discovery is a complex, challenging, and iterative hunt for novel new medicines to address the unmet medical needs of patients. The science and considerations behind this endeavor are covered in this online specialization composed of 6 courses, which begins with an Introduction to Drug Hunting, followed by in-depth discussions of Targets, Assays and Screening, Lead Selection and Optimization, Pharmacokinetics, Preclinical Safety, and Preformulation. The specialization is self-paced, with each course comprised of short 5-minute videos covering selected topics, accompanied by additional readings and problems designed to reinforce and deepen understanding of those topics
Erland Stevens, PhD
James G. Martin Professor of Chemistry, Davidson College
W. Ross Tracey, PhD
Associate Director, Biomedical Research Learning, Novartis
Douglas S. Auld, PhD
Associate Director, Discovery Sciences, Biomedical Research, Novartis
Alan P. Brown, PhD, DABT
Director, Preclinical Safety, Biomedical Research, Novartis